KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rayonier (RYN) Cash & Equivalents (2016 - 2025)

Rayonier has reported Cash & Equivalents over the past 17 years, most recently at $842.9 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $842.9 million for Q4 2025, up 178.14% from a year ago — trailing twelve months through Dec 2025 was $842.9 million (up 178.14% YoY), and the annual figure for FY2025 was $842.9 million, up 178.14%.
  • Cash & Equivalents for Q4 2025 was $842.9 million at Rayonier, down from $919.6 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for RYN hit a ceiling of $919.6 million in Q3 2025 and a floor of $51.9 million in Q3 2024.
  • Median Cash & Equivalents over the past 5 years was $238.0 million (2022), compared with a mean of $304.9 million.
  • Biggest five-year swings in Cash & Equivalents: crashed 68.46% in 2023 and later surged 1670.27% in 2025.
  • Rayonier's Cash & Equivalents stood at $362.2 million in 2021, then plummeted by 68.45% to $114.3 million in 2022, then skyrocketed by 81.78% to $207.7 million in 2023, then soared by 45.92% to $303.1 million in 2024, then skyrocketed by 178.14% to $842.9 million in 2025.
  • The last three reported values for Cash & Equivalents were $842.9 million (Q4 2025), $919.6 million (Q3 2025), and $892.3 million (Q2 2025) per Business Quant data.